Lowell Thomas Holden - 27 Jan 2023 Form 4 Insider Report for Nascent Biotech Inc.

Role
CFO, Director
Signature
/s/ Lowell Holden
Issuer symbol
NBIO on OTC
Transactions as of
27 Jan 2023
Net transactions value
+$2,800
Form type
4
Filing time
02 Feb 2023, 11:47:04 UTC
Previous filing
03 Jan 2023
Next filing
14 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NBIO Common Stock Purchase $2,800 +20,000 +0.24% $0.1400* 8,418,277 27 Jan 2023 Direct
holding NBIO Common Stock 2,000,000 27 Jan 2023 Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.